Newman; Roland Anthony

Patent Applications and Registrations

Patent applications and USPTO patent grants for Newman; Roland Anthony.The latest application filed is for "recombinant anti-cd4 antibodies for human therapy".

Company Profile

0.8.3

Newman; Roland Anthony - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant Anti-cd4 Antibodies For Human Therapy App 20090226430 - HANNA; Nabil ; et al.	2009-09-10
Recombinant Anti-cd4 Antibodies For Human Therapy App 20090221036 - Hanna; Nabil ; et al.	2009-09-03
Recombinant anti-CD4 antibodies for human therapy Grant 7,452,534 - Hanna , et al. November 18, 2	2008-11-18
Recombinant anti-CD4 antibodies for human therapy Grant 7,338,658 - Hanna , et al. March 4, 2	2008-03-04
Recombinant anti-CD4 antibodies for human therapy App 20030077275 - Hanna, Nabil ; et al.	2003-04-24
Recombinant anti-CD4 antibodies for human therapy Grant 6,136,310 - Hanna , et al. October 24, 2	2000-10-24
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof Grant 5,955,364 - Brams , et al. September 21, 1	1999-09-21
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof Grant 5,939,068 - Brams , et al. August 17, 1	1999-08-17
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof Grant 5,866,125 - Brams , et al. February 2, 1	1999-02-02
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof Grant 5,840,298 - Brams , et al. November 24, 1	1998-11-24
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof Grant 5,811,524 - Brams , et al. September 22, 1	1998-09-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.